Tri-GalNAc-PEG4-DBCO combines a hepatocyte-targeting Tri-GalNAc ligand for ASGPR with a DBCO group for strain-promoted click chemistry (SPAAC), enabling targeted delivery of molecules like antibodies or small molecules and efficient conjugation with azide-functionalized molecules for advanced therapeutic applications. The PEG4 linker enhances the hydrophilicity of the compound
Usually ships within 24 hours.